Trial Profile
A Trial to Assess Expanded Safety, Acceptability and Preliminary Effectiveness of Carraguard (PC-515) in Preventing STI/HIV Transmission
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 17 Aug 2017
Price :
$35
*
At a glance
- Drugs PC 515 (Primary)
- Indications Gonorrhoea; HIV infections; Trachoma; Treponema infections; Trichomoniasis
- Focus Adverse reactions; Therapeutic Use
- 18 Feb 2011 New trial record